List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1594 studies with search of: "Immunoglobulins"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma
Conditions: Carcinoma, Renal Cell;   Melanoma
Interventions: Biological: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ) Monoclonal Antibody;   Biological: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ) Monoclonal Antibody;   Biological: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ) Monoclonal Antibody;   Biological: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ) Monoclonal Antibody;   Biological: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ) Monoclonal Antibody;   Biological: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ) Monoclonal Antibody;   Biological: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ ) Monoclonal Antibody;   Biological: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ) Monoclonal Antibody
2 Terminated Intravenous Immunoglobulin After Relapse in Vasculitis
Conditions: ANCA + Vasculitides Relapsing Either Under Corticosteroid;   and Immunosuppressant Therapies or After One Year;   Post Treatment.
Intervention: Drug: Intravenous immunoglobulins (human immunoglobulins G)
3 Recruiting Efficacy of High-Dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease
Conditions: Hyperbilirubinemia;   Erythroblastosis, Fetal
Interventions: Drug: Intravenous Immunoglobulin;   Drug: Normal saline solution
4 Recruiting Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage
Condition: Secondary Recurrent Miscarriage
Interventions: Drug: Intravenous immunoglobulin;   Drug: Human albumin
5 Withdrawn Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: monoclonal antibody anti-anb3 integrin;   Procedure: anti-cytokine therapy;   Procedure: antiangiogenesis therapy;   Procedure: antibody therapy;   Procedure: biological response modifier therapy;   Procedure: growth factor antagonist therapy;   Procedure: monoclonal antibody therapy
6 Recruiting A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Drug: Immune Globulin Intravenous (Human), 10% (IGIV, 10%);   Drug: Immune Globulin Intravenous (Human), 10% (IGIV, 10%);   Other: Placebo solution
7 Not yet recruiting Intravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated Cardiomyopathy
Conditions: Myocardial Diseases;   PVB19 Viral Load
Interventions: Drug: Intravenous Immunoglobulins;   Drug: plasma volume expander
8 Completed Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Interventions: Drug: Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified;   Drug: Albumin (Human) 25%, USP
9 Completed Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
Condition: Multifocal Motor Neuropathy
Interventions: Drug: Subcutaneous immunoglobulin;   Drug: Intravenous immunoglobulin
10 Completed Safety and Efficacy of Bovine Milk Immunoglobulin Against CS17 and CsbD
Condition: Travelers' Diarrhea
Interventions: Other: Anti Cs17 Bovine Milk Immunoglobulin;   Other: Anti CsbD Bovine Milk Immunoglobulin;   Other: Lacto-free milk supplement
11 Completed Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplantation
Condition: Hepatitis B, Chronic
Intervention: Drug: Specific intravenous anti-hepatitis B immunoglobulin
12 Completed Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin
Conditions: Common Variable Immunodeficiency;   Agammaglobulinemia
Intervention: Biological: gammaglobulin
13 Completed Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified
14 Completed Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
Conditions: Renal Failure, Chronic;   Renal Transplantation
Interventions: Drug: intravenous immunoglobulins (IVIG);   Procedure: kidney transplantation
15 Recruiting Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins
Condition: Multiple System Atrophy
Intervention: Drug: intravenous immunoglobulin (IVIg)
16 Recruiting Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)
Condition: Anthrax
Interventions: Biological: Anthrax Immune Globulin Intravenous (AIGIV);   Biological: Gamunex
17 Recruiting Immunoadsorption and Immunoglobulin Substitution for Heart Failure After Myocardial Infarction
Conditions: Heart Failure;   Coronary Heart Disease
Intervention: Device: Immunoadsorption / Immunoglobulin substitution
18 Recruiting Treatment of Deficient Subclass or Anti-Polysaccharide Antibody Response
Conditions: IgG Deficiency;   Infections
Interventions: Drug: intravenous immunoglobulins;   Drug: co-trimoxazole
19 Active, not recruiting Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Condition: Prostate Cancer
Interventions: Biological: filgrastim;   Biological: monoclonal antibody m170;   Drug: cyclosporine;   Drug: paclitaxel;   Procedure: peripheral blood stem cell transplantation;   Radiation: indium In 111 monoclonal antibody m170;   Radiation: yttrium Y 90 monoclonal antibody m170
20 Active, not recruiting Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: monoclonal antibody Lym-1;   Drug: cyclosporine;   Drug: paclitaxel;   Radiation: indium In 111 monoclonal antibody Lym-1;   Radiation: yttrium Y 90 monoclonal antibody Lym-1

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services